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Abstract
Background: Anaemic status is determined by haemoglobin using the HemoCue system or
haematocrit measurements, and a threefold conversion is commonly used to equate the two
measures (haemoglobin = haematocrit/3). The validity of this conversion in malaria endemic
settings was assessed.
Methods: Concurrent measures of haemoglobin and centrifuged haematocrit in children aged 6–
59 months were compared by modelling the difference between the two measures against their
average. A random effects linear regression of the difference of the measures on their average was
used to describe the line of best agreement and 95% limits of agreement for these two measures
over a range of values after adjusting for statistically significant covariates.
Results: There was a consistent bias between the two measures, with haemoglobin less than
haematocrit/3 in 87% (899/1,030) of observations. This difference was non-uniform, decreasing
with the average measure, i.e. less difference at higher haemoglobin and haematocrit values. In
these studies, use of haematocrit would have underestimated the prevalence of anaemia by
misclassifying 10% (89/920) of individuals with haemoglobin < 11 g/dl, 66% (252/380) of individuals
with haemoglobin < 8 g/dl and 100% (23/23) of individuals with haemoglobin < 5 g/dl. The mean
difference between the measures was greater in males than females, increased with age between
6–59 months, and was greater in the wet than dry season suggesting that the relationship between
haemoglobin and haematocrit may be modified by exposure to malaria.
Conclusion:  The regression model indicated that the standard threefold conversion from
haematocrit to haemoglobin underestimates the prevalence of haemoglobin < 11 g/dl in children
under five years of age in malaria endemic settings. This bias was more acute for more severe
anaemia defined by haemoglobin < 8 g/dl and haemoglobin < 5 g/dl. This has important implications
for the comparability of studies using these different measures. Direct determination of
haemoglobin should be the measurement of choice for assessing anaemia outcomes in malaria
intervention trials and surveys.
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Background
Anaemia is increasingly being used as an indicator of the
impact of malaria control in intervention trials [1-8] and
for monitoring and evaluation by the Roll Back Malaria
Partnership [9]. Typically anaemia is determined by meas-
uring haemoglobin (Hb) concentration. However, packed
cell volume or haematocrit (Hct) has been widely used as
an alternative to haemoglobin in malaria studies
[1,2,4,10-19]. A standard threefold conversion between
the two measures (Hb = Hct/3) is commonly used to
define cut-offs for estimating the prevalence of anaemia
[20], despite concerns about the accuracy of haematocrit
[21-23]. To be able to compare and combine data from
multiple studies using different methods of anaemia
measurement [24], the comparability of haemoglobin
assessed spectrophotometrically using HemoCue and
haematocrit was investigated in samples from children
aged 6–59 months from two malaria endemic settings.
Methods
Sample collection
Data from two studies that have measured haemoglobin
and haematocrit were used to assess the reliability of the
standard threefold conversion factor. Finger-prick blood
samples were collected for determination of malaria and
anaemia status from 968 children aged 6–18 months
from cross-sectional surveys in the dry and wet seasons of
2000 in Navrongo, Ghana [2] and from 62 children aged
6–59 months from a cross-sectional survey in the dry sea-
son of 2001 in Kwemasimba, north-east Tanzania [25]. In
both studies, haemoglobin concentration was assessed by
haemophotometry (HemoCue, Ängelholm, Sweden), and
haematocrit was assessed by centrifugation using standard
procedures for Hawksley microhaematocrit tubes and
centrifuge (Hawksley & Sons Ltd, Sussex, UK) i.e. 10 min-
utes at a fixed speed of 11,000 rpm.
Statistical methods
Bland & Altman [12] argue that two methods designed to
measure the same thing will inevitably give a positive lin-
ear regression, and the most useful comparison is gained
by plotting the difference between the measures against
the mean of the two measures. This method was used to
compare haemoglobin (g/dl) and haematocrit (%)
divided by a factor of three [20] to be able to compare the
measurements on approximately the same scale ("grams
of haemoglobin per dl"). The difference between the hae-
moglobin and haematocrit/3 measurements (i.e. Hb -
Hct/3) and the mean of the two measurements (i.e. (Hb +
Hct/3)/2 – now called average to avoid confusion with
mean difference), were calculated for each individual. Lin-
ear regression analyses were used to define the relation-
ship between the mean difference and the average of the
two measures [26], adjusting for a priori covariates of age,
sex, season and Plasmodium falciparum infection status. A
random effects model was used to adjust for potential
intra-cluster correlation of observations from the same
study. The final regression model was used to define the
line of best agreement between haemoglobin and haema-
tocrit, and the 95% limits of agreement were calculated as
+/- 1.96 standard deviations (SD) [26]. There was only
one average value greater than 14 g of haemoglobin per
dl, and this was excluded as it was judged to be an outlier
value, and there would be insufficient statistical power to
model the relationship above 14 g of haemoglobin per dl.
Results
Haemoglobin measurements were lower than haemat-
ocrit/3 in both studies, with a linear trend in the relation-
ship so that less negative differences were seen with
increasing haemoglobin levels (Figure 1). Logarithmic
transformations of the means and differences as suggested
by Bland & Altman [27] did not improve this relationship.
The results of the random effects linear regression analysis
are presented in Table 1. The difference between haemo-
globin and haematocrit showed a statistically significant
decrease with the average of the two measures, increased
with age, was greater in the wet compared with the dry
season and was greater in males than females. The greater
difference in individuals with P. falciparum infection than
in those without in the univariate analyses, no longer
remained significant in the multivariate analysis, but was
kept in the model as an a priori covariate.
The final regression model gave the following relation-
ship, which represents the line of best agreement between
the two measures:
Diff = - 2.33 + 0.17 × Ave - 0.23 × Age - 0.08 × Pf - 0.66 × 
Season + 0.21 × Sex (1)
Scatter-plots of difference against average of haemoglobin  and haematocrit/3 for each study Figure 1
Scatter-plots of difference against average of haemo-
globin and haematocrit/3 for each study. Scatter-plots 
of difference against average of haemoglobin and haemat-
ocrit/3 for paired measurements from children aged 6–59 
months. The line of best fit (red) indicates a trend towards 
greater differences at lower haemoglobin values. Both axes 
are in "grams of haemoglobin/dl".Malaria Journal 2007, 6:67 http://www.malariajournal.com/content/6/1/67
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where Diff represents the estimated difference between
the two methods, and Ave represents the average of the
two methods. Age is in years where 0 actually represents
6–11 months, Pf is the concurrent presence (= 1) or
absence (= 0) of P. falciparum infection in the child, Sea-
son is wet (= 1) or dry (= 0), and Sex is male (= 0) or
female (= 1).
A regression of the absolute values of the residuals from
this model on the average of the two measures found no
relationship (P = 0.252). Therefore, the standard devia-
tion (SD) of the adjusted difference was estimated as the
residual SD from the regression model [26], and the 95%
limits of agreement were calculated as the regression
model ± 1.96 × SD. This is not a confidence interval as it
is calculated from the regression model rather than the
data, but it provides a reference interval within which
95% of the differences between the two measurements are
expected to lie.
In practice, to obtain the estimated difference between the
two measurements, Ave can be substituted by any single
observed value (i.e. either haemoglobin or haematocrit/
3). Equation 1 can be rearranged as
Hb - Hct/3 = -2.33 + 0.17 × Hct/3 - 0.23 × Age - 0.08 × Pf 
- 0.66 × Season + 0.21 × Sex
to give the predicted haemoglobin value for any given
value of haematocrit from:
Hb = (1.17 × Hct/3) -2.33 - 0.23 × Age - 0.08 × Pf - 0.66 × 
Season + 0.21 × Sex (2)
Figure 2 shows the line of best agreement between the
haemoglobin and haematocrit measurements for individ-
uals under different scenarios of age, season, sex and P.
falciparum infection, with the regression-based 95% limits
of agreement around these lines. For females aged 6–11
months in the dry season with no P. falciparum infection
(Figure 2a), the line of best agreement is higher, but not
statistically significantly, than the standard threefold con-
version, and the two are equivalent above 12 g/dl of hae-
moglobin. However, for males aged 4 years in the wet
season with P. falciparum infection (Figure 2b), the line of
best agreement is consistently above the standard three-
fold conversion, and this difference is significant between
4–11 g/dl of haemoglobin. To develop a comparison
between haemoglobin and haematocrit for an "average"
individual in these settings, average values for age (2
years), sex (0.5), season (0.5) and P. falciparum infection
(0.5) were substituted into the model. Table 2 shows val-
ues from this "average" model and demonstrates how the
standard haematocrit cut-offs used to define anaemia
(haematocrit < 33%), moderate anaemia (haematocrit <
24%) and severe anaemia (haematocrit < 15%) are likely
to underestimate the burden of anaemia compared to
haemoglobin measurements using cut-offs of haemo-
globin < 11 g/dl, haemoglobin < 8 g/dl and haemoglobin
< 5 g/dl respectively. This model suggests that on average
for children aged 6–59 months in malaria endemic areas,
more appropriate cut-offs may be haematocrit < 36% for
all anaemia, haematocrit < 28% for moderate anaemia
and haematocrit < 21% for severe anaemia. The actual
Table 1: Coefficients from linear regression of difference between haemoglobin and haematocrit/3 (expressed as "g of haemoglobin/
dl")
Covariates Univariate coefficient(95% CI) P-value Multivariate coefficient (95% CI) P-value
Average of Hb & Hct/3
4.5 "g of Hb/dl" -3.70 (-4.06, -3.34)§ < 0.001 -2.33 (-2.78, -1.89)§ < 0.001
Each additional "g of Hb/dl" +0.28 (+0.24, +0.32) < 0.001 +0.17 (+0.13, +0.22) < 0.001
Age:
6 – 12 months -1.07 (-1.14, -0.99)§ < 0.001 -2.33 (-2.78, -1.89)§ < 0.001
Each additional 1 year of age -0.26 (-0.36, -0.16) < 0.001 -0.23 (-0.32, -0.15) < 0.001
P. falciparum infection:
No -0.92 (-1.01, -0.84)§ < 0.001 -2.33 (-2.78, -1.89)§ < 0.001
Yes -0.58 (-0.71, -0.45) < 0.001 -0.08 (-0.21, +0.05) 0.23
Season:
Dry -0.57 (-.066, -0.48)§ < 0.001 -2.33 (-2.78, -1.89)§ < 0.001
Wet -0.99 (-1.11, -0.87) < 0.001 -0.66 (-0.80, -0.51) < 0.001
Sex:
Male -1.28 (-1.37, -1.19)§ < 0.001 -2.33 (-2.78, -1.89)§ < 0.001
Female +0.26 (+0.13, +0.39) < 0.001 +0.21 (+0.09, +0.32) < 0.001
§ Denotes the constant in the model – i.e. the reference category to which additional coefficients must be addedMalaria Journal 2007, 6:67 http://www.malariajournal.com/content/6/1/67
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conversion will vary with the covariates discussed above,
so the alternative cut-offs presented are indicative of the
potential magnitude of the problem of using haematocrit,
and are not intended for use as an adjusted conversion
table in research or clinical practice.
Discussion
The results showed a consistent bias of haemoglobin
measurements to indicate a greater degree of anaemia
than haematocrit measurements in the same individuals
and populations if the standard threefold conversion is
used, as has been reported previously [22]. As this is a sec-
ondary analysis of data collected for a different purpose,
one potential source of error could be a systematic bias in
the haemodilution of the finger-prick sample collection.
In both studies a malaria blood smear was made, then the
haematocrit sample was taken and finally the sample for
haemoglobin. However, differences between haemo-
globin and haematocrit measurements have also been
described in studies using venous blood [22,23], making
this an unlikely explanation for the differences seen here.
Centrifuged haematocrit, as used here, has previously
been shown to give falsely elevated results compared with
comparative Coulter-derived measurements [28]. How-
ever, data from 108 individuals aged 1–4 years from a
study in Dielmo, Senegal [29] using Coulter-derived
measurement of haematocrit also showed a bias of hae-
matocrit to underestimate anaemia compared with hae-
moglobin. In that study, haematocrit/3 was consistently
0.72 g/dl of haemoglobin below the haemoglobin meas-
urement but did not vary with any other covariates [24].
The difference between the haemoglobin and centrifuged
haematocrit/3 was found to be non-uniform, increasing
with average values of these measures, and modified by
age, season and sex. These results suggest that the relation-
ship between haemoglobin and centrifuged haematocrit
is modified by recent exposure to malaria, as younger age
and wet season are both strong correlates of increased
malaria exposure.
The error in centrifuged haematocrit measurements can
be due to plasma trapping between the packed red cells,
and the amount of plasma trapping has been shown to
vary according to red cell size (mean corpuscular volume
(MCV)), being higher with macrocytes, and increasing
with reducing mean corpuscular haemoglobin concentra-
tion (MCHC) in hypochromic anaemias [21]. Although
plasma trapping was not reported to vary with haemo-
globin levels per se, previous results were consistent with
a reduced amounts of plasma trapped with increasing
haemoglobin levels [21].
Malaria produces normocytic and normochromic anae-
mia, where the size of the red cells and haemoglobin con-
centration within the red cells is within the normal range
(i.e. MCV = 80–100 fl and MCHC = 320–360 g/l). Red cell
destruction during a malaria infection leads to a subse-
quent increase in erythropoeisis and, thus, increases in the
proportion of reticulocytes in individuals recovering from
a symptomatic malaria episode [30]. Reticulocytes have a
larger MCV and lower MCHC and may act in a similar way
to macrocytes and hypochromic cells to increase plasma-
trapping following a symptomatic malaria episode. In
addition, there are several other conditions that affect red
cell size and composition such as micronutrient deficien-
cies (e.g. folate or iron deficiency) and genetic effects (e.g.
alpha thalassaemia, sickle cell disease), and these can be
relatively common in malaria endemic settings.
Conclusion
The conversion between haematocrit and haemoglobin
has been shown to vary with age, sex and season of survey,
in malaria-endemic settings, and, therefore, there is no
Table 2: Comparison of haematocrit and haemoglobin for an 
average malaria-endemic African population under-5
Observed 
Hb (g/dl)
Estimated Hct (%) 
using Hb × 3
Actual equivalent Hct 
(95% limits of agreement)
4 12 18.1 (12.7, 23.5)
5 15 20.7 (15.2, 26.1)
6 18 23.2 (17.8, 28.6)
7 21 25.8 (20.4, 31.2)
8 24 28.3 (22.9, 33.8)
9 27 30.9 (25.5, 36.3)
10 30 33.5 (28.0, 38.9)
11 33 36.0 (30.6, 41.5)
12 36 38.6 (33.2, 44.0)
13 39 41.2 (35.7, 46.6)
Line of best agreement between haemoglobin and haemat- ocrit for different scenarios Figure 2
Line of best agreement between haemoglobin and 
haematocrit for different scenarios. The line of best 
agreement between haemoglobin (g/dl) and haematocrit (%) 
is given by the solid red line, with the 95% limits of agree-
ment shaded grey. The dashed blue line shows the standard 
threefold conversion. Graph (a) shows the comparison for 
females aged 6–11 months with no malaria infection during 
the dry season, Graph (b) shows the comparison at the other 
extreme for males aged 4 years with malaria infection during 
the wet season.Malaria Journal 2007, 6:67 http://www.malariajournal.com/content/6/1/67
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simple conversion factor between the two. Thus, while the
cause of the differences seen here between haematocrit
and haemoglobin measurements is not known, our data
argue for the consistent use of haemoglobin rather than
haematocrit in the measurement of anaemia in malaria-
endemic settings.
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